July 4 (Reuters) - Merus Labs International Inc MSL.TO :
* Merus announces reduced leverage and provides business
update
* Recent depreciation of pound sterling post Brexit vote is
expected to impact company's EBITDA by approximately 1 pct
* Sees 2016 adjusted EBITDA, without consideration of
additional acquisitions, to be in $47 million to $50 million
range
* Integration plans with previously acquired products from
Novartis, UCB and Sanofi (PA:SASY) remain on schedule
* Says less than 10% of merus' total sales are in UK
* Reiterating its 2016 guidance
Source text for Eikon:
Further company coverage: MSL.TO
(Bengaluru Newsroom: +1-646-223-8780)